Rook Security, an 11-year-old firm that specializes in cyber-threat detection and response services, had been on a torrid growth pace for most of this decade but has downsized its workforce more than 60 percent over the past three years.
The deal, which closed this week, gives Fountain Square Brewing access to New Day’s lines of mead and hard cider as it tries to widen its distribution footprint.
As a result of the deal, Jon Russell, the son of Celadon co-founder Steve Russell, is expected to leave the company for a management position with the acquiring firm.
The president’s comments dim hopes that round-the-clock trade negotiations between the world’s two biggest economies could lead to them removing the roughly $360 billion in tariffs they’ve imposed on each other’s imports.
In central Indiana and nationwide, a number of small companies are changing hands right now—and for a variety of reasons. Among them: a strong economy, plentiful buyers and an aging population of owners who are eyeing retirement.
Experts are mixed on whether the buyout barrage is cause for concern or validation of success.
Drug industry analysts on Monday applauded Eli Lilly and Co.’s pending $8 billion cash deal to buy a startup that focuses on oncology, which has become a prime focus for the pharma giant in the last year.
Orbis was founded in 2003 by Daniel Briggs, who now serves as the company’s chief growth officer. The firm markets and manages health care programs for academic institutions and health care systems.
NattyMac, which was established in 2004, has a historical connection with Indianapolis and was sold to its current owner in 2017 for $211 million.
Randy Stocklin, who founded the company with his wife, Angie Stocklin, will remain with the company.
The escalation in per-share price—which far exceeds that of other recent deals involving Indiana public companies—reflects the unique nature of M&A in the pharmaceutical realm.
The West Lafayette biotech firm’s stock traded as low as $1.41 last fall, following multiple setbacks and restructurings. But the stock had soared to $24 Thursday morning after news that it would be acquired by Novartis.
The deal represents a huge breakthrough for tiny Endocyte, which has about 90 employees in Indiana but has not yet launched a single product.
Anger expression is on the rise in the workplace and especially in business negotiations. If you use anger to get the bigger piece of the pie, you might think it’s an effective negotiation tactic.
The Indianapolis-based office-supplies company had revenue near $38 million last year and is on target to hit $43 million this year. If the company hits its projections, revenue will have nearly tripled since 2013.
General Electric Co. has agreed to sell its industrial gas engine business to a private equity for $3.25 billion, passing over interest in the acquisition from Columbus-based Cummins Inc.
Founded in 2016, ClearScholar is the second company in the High Alpha portfolio to be snapped up in the last four months.
It’s been a bumpy ride for North American Midway Entertainment, which was sold in 2015 to a Connecticut-based buyer for $75.5 million. One of its former owners just bought it back for $23.5 million.
Business history is littered with colossally bad mergers that seemed brilliant at the time. So the insurer might benefit from avoiding the temptation to follow the current trend. Or it could get left in the dust.
Under the agreement, Lilly will pay Sigilon Therapeutics up to $410 million if the technology hits certain milestones.
